Trevi Therapeutics
TRVI
#4849
Rank
HK$14.13 B
Marketcap
HK$110.26
Share price
9.09%
Change (1 day)
433.16%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2025 (TTM): -HK$0.36 Billion

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.38 Billion a decrease over its 2023 earnings that were of -HK$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.36 Billion-4.1%
2024 -HK$0.38 Billion67%
2023 -HK$0.23 Billion2.43%
2022 -HK$0.22 Billion-14.45%
2021 -HK$0.26 Billion1.36%
2020 -HK$0.26 Billion23.64%
2019 -HK$0.21 Billion27.54%
2018 -HK$0.16 Billion